Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges

Código QR

Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges

Dionisios Spyratos, Eleni Papadaki, Sofia Lampaki, Theodoros Kontakiotis Pulmonary Department, Lung Cancer Oncology Unit, Aristotle University of Thessaloniki, G. Papanicolaou Hospital, Thessaloniki, Greece Abstract: Chronic obstructive pulmonary disease (COPD) and lung ca...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Spyratos D, Papadaki E, Lampaki S, Kontakiotis T
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	lung cancer COPD coexistence risk factor therapy decisions Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/c4e5e5ca53924b9f9ac15b74495c7e74
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Potential of Stem Cells and CART as a Potential Polytherapy for Small Cell Lung Cancer
por: Evgenii Skurikhin, et al.
Publicado: (2021)

Quantification of Cancer-Developing Idiopathic Pulmonary Fibrosis Using Whole-Lung Texture Analysis of HRCT Images
por: Chia-Hao Liang, et al.
Publicado: (2021)

Racial Differences in Prevalence and Clinical Characteristics of Asthma–Chronic Obstructive Pulmonary Disease Overlap
por: Yong Suk Jo, et al.
Publicado: (2021)

Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases
por: Passi M, et al.
Publicado: (2020)

Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism
por: Di W, et al.
Publicado: (2021)

Serum CYR61 Is Associated With Airway Inflammation and Is a Potential Biomarker for Severity in Chronic Obstructive Pulmonary Disease
por: Zhu-Xia Tan, et al.
Publicado: (2021)

New Insights into the Role of NLRP3 Inflammasome in Pathogenesis and Treatment of Chronic Obstructive Pulmonary Disease
por: Zhang J, et al.
Publicado: (2021)

COMPARISON OF SPIROMETRY DATA AND SYMPTOMS BETWEEN MALE AND FEMALE SMOKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
por: Rida Khan, et al.
Publicado: (2021)

Impact of Chronic Obstructive Pulmonary Disease on the Mortality of Patients with Small Cell Lung Cancer
por: Liao KM, et al.
Publicado: (2021)

Lung cancer risk in non-smoking females with a familial history of cancer: a multi-center prospective cohort study in China
por: Fei Wang, et al.
Publicado: (2021)

Epidemiology of lung cancer
por: Krishna Chaitanya Thandra, et al.
Publicado: (2021)

Adaptive Radiation Therapy in the Treatment of Lung Cancer: An Overview of the Current State of the Field
por: Huzaifa Piperdi, et al.
Publicado: (2021)

Characteristics and Prevalence of Early Chronic Obstructive Pulmonary Disease in a Middle-Aged Population: Results from a Nationwide-Representative Sample
por: Kim T, et al.
Publicado: (2021)

Analysis of lung cancer measures of the National Cancer Network pilot study in Poland for potential improvement in the quality of advanced-stage lung cancer therapy
por: Łukasz Trembecki, et al.
Publicado: (2021)

Optimal delivery of follow-up care following pulmonary lobectomy for lung cancer
por: Chen YY, et al.
Publicado: (2016)

Lung cancer in Brazil: epidemiology and treatment challenges
por: de Sá VK, et al.
Publicado: (2016)

Osimertinib Re-challenge for EGFR-mutant NSCLC after  Osimertinib-induced Interstitial Lung Disease: A Case Report
por: Junjie GU, et al.
Publicado: (2021)

Surgical treatment for synchronous multiple primary lung cancer: Is it possible to achieve both curability and preservation of the pulmonary function?
por: Takuya Watanabe, et al.
Publicado: (2021)

Successful treatment of locally advanced lung cancer using late concurrent chemoradiation therapy administered after immune checkpoint inhibitor plus platinum chemotherapy
por: Taichi Matsubara, et al.
Publicado: (2021)

Predictive Risk Factors for Early Recurrence of Stage pIIIA-N2 Non-Small Cell Lung Cancer
por: Yu Q, et al.
Publicado: (2021)

The aging lung
por: Lowery EM, et al.
Publicado: (2013)

Predictores clínicos y funcionales del riesgo de cáncer pulmonar en el seguimiento de una cohorte de adultos fumadores
por: Saldías Peñafiel,Fernando, et al.
Publicado: (2016)

An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece
por: Mountzios G, et al.
Publicado: (2021)

Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma
por: Thakur MK, et al.
Publicado: (2017)

Tumor Lysis Syndrome following a Single Dose of Nivolumab for Relapsed Small-Cell Lung Cancer
por: Sarah Maryon Hayes, et al.
Publicado: (2021)

Fatigue in lung cancer patients: symptom burden and management of challenges
por: Carnio S, et al.
Publicado: (2016)

Prospects for the development of adjuvant therapy for non-small cell lung cancer
por: K. K. Laktionov, et al.
Publicado: (2020)

Adjuvant targeted therapy for non-small cell lung cancer
por: Konstantin K. Laktionov, et al.
Publicado: (2020)

Paracrine Regulation of Alveolar Epithelial Damage and Repair Responses by Human Lung-Resident Mesenchymal Stromal Cells
por: Dennis M. L. W. Kruk, et al.
Publicado: (2021)

Extracellular Vesicles in Lung Cancer Metastasis and Their Clinical Applications
por: Michela Saviana, et al.
Publicado: (2021)

Human Lung Macrophages Challenged to Oxidants ex vivo: Lysosomal Membrane Sensitization is Associated with Inflammation and Chronic Airflow Limitation
por: Persson HL, et al.
Publicado: (2020)

Lung cancer international

Psychosocial challenges for patients with advanced lung cancer: interventions to improve well-being
por: Lehto RH
Publicado: (2017)

CHARACTERISTICS OF LOCAL INFLAMMATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DEPENDENCE ON SEVERITY STAGE
por: L. Yu. Dolinina, et al.
Publicado: (2014)

miRNA-21 as a novel therapeutic target in lung cancer
por: Markou A, et al.
Publicado: (2016)

Reference Equations for Assessing the Physical Activity of Japanese Patients with Chronic Obstructive Pulmonary Disease
por: Minakata Y, et al.
Publicado: (2021)

Antimicrobial and Anti-Inflammatory Activity of Apple Polyphenol Phloretin on Respiratory Pathogens Associated With Chronic Obstructive Pulmonary Disease
por: Rahel L. Birru, et al.
Publicado: (2021)

ASSESSMENT OF CYTOCHROME C OXIDASE ACTIVITY IN WHITE BLOOD CELLS OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
por: MS Hakhamaneshi,, et al.
Publicado: (2008)

Lobar Gross Endobronchial Disease Predicts for Overall Survival and Grade 5 Pulmonary Toxicity in Medically Inoperable Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
por: Nima Aghdam, et al.
Publicado: (2021)

Magnesium isoglycyrrhizinate inhibits airway inflammation in rats with chronic obstructive pulmonary disease
por: Ye Yang, et al.
Publicado: (2021)